Avoro Capital Advisors rose 10% in March, driven by a notable surge in United Therapeutics on positive Phase 3 trial results. This performance contrasts with the broader market dynamics, particularly impacting hedge fund strategies in biopharma. www.institutionalinvestor.com/article/biop...
Posts by Institutional Investor
Recent performances of Kailera Therapeutics and Alamar Biosciences have led biopharma issuers, many with hedge fund backing, to renew their IPOs. As six companies have filed to go public recently, market sentiment is visibly shifting. www.institutionalinvestor.com/article/prem...
Irenic Capital Management is raising $220 million for a new SPAC, aiming to target established aerospace, defense, and electrification-linked industrial businesses, amidst growing demand and supply chain constraints. www.institutionalinvestor.com/article/iren...
Dana Johns leads a private equity portfolio exceeding $11 billion at the Maryland State Retirement and Pension System, having increased its allocation target significantly over the last decade.
www.institutionalinvestor.com/article/mark...
Sophia Cheng, CIO of Cathay Financial Holdings, manages nearly $400 billion in assets, with over 60% allocated to fixed income. Her approach emphasizes patience and a long-term vision amidst global market shifts. www.institutionalinvestor.com/article/mark...
Investor advocates urge FASB to reassess its guidance allowing secondary fund managers to mark up purchases, risking inflated returns. This raises concerns about market distortions and implications for capital flows in private equity. www.institutionalinvestor.com/article/inve...
U.S. and Canadian institutions have doubled their ETF use in five years, now at $337 billion, notably leveraging them to enhance tactical flexibility. This shift is redefining portfolio construction for asset managers. www.institutionalinvestor.com/article/etfs...
New data reveal that most LPs perceive AI as essential for the future, acknowledging the obsolescence of their investment models. Ambroz asserts that while AI can enhance efficiency, it will not replace the necessity for human investment staff. www.institutionalinvestor.com/article/allo...
Avoro Capital Advisors topped biopharma hedge funds in March, up 10% on United Therapeutics' 18% surge. Fund performance is increasingly driven by single-stock moves, not broad market shifts.1
www.institutionalinvestor.com/article/biop...
Investor advocates urge the FASB to rethink guidance allowing private equity managers to inflate secondary fund valuations, which critics claim distort performance perceptions. This could lead to significant ramifications for investor confidence.
www.institutionalinvestor.com/article/inve...
Only 8.8% of allocators understand the risks in their portfolios, with over 42% fearing they will fall behind in five years. Many see AI as critical for navigating the complexities of private markets. www.institutionalinvestor.com/article/surv...
Investor advocates urge the FASB to reconsider guidance allowing private managers to mark up the value of secondary purchases. This practice raises concerns over inflated reported returns and potential risks for individual investors. www.institutionalinvestor.com/article/inve...
BlackRock projects over $5 trillion in capital expenditures through 2030 to enable AI-driven productivity, creating persistent inflationary pressures. Hedge funds may capitalize on more volatile market conditions as supply shocks become commonplace.
www.institutionalinvestor.com/article/blac...
TCI Fund Management's Chris Hohn reported an 11.9% drop in March, significantly worse than broader markets, with the S&P 500 down 4.6%. This decline impacts institutional investors relying on hedge fund stability.
www.institutionalinvestor.com/article/tci-...
Glenview Capital Partners, down 10.13% in Q1 after losing 7.16% in March, has recovered to near breakeven by mid-April, reflecting potential improvements across other hedge funds post-market rebound.
www.institutionalinvestor.com/article/prem...
The Saginaw Chippewa Indian Tribe's investment office reduced the performance gap among its accounts from 44 to 11 basis points by automating capital deployment. This efficiency narrows discrepancies between inflow and outflow-driven accounts.
www.institutionalinvestor.com/article/perf...
New data reveals that only 8.8% of allocators understand their portfolio risks, with 42% fearing obsolescence in five years. As complexity grows, LPs increasingly turn to AI, highlighting the urgency for technological integration in investment processes.
www.institutionalinvestor.com/article/surv...
S&P Global Market Intelligence reports a 22% drop in private equity deal volume year-over-year, while values increased to $154.64 billion. This leads allocators like University of Rochester's Rob Rahbari to cut new commitments amid liquidity issues. www.institutionalinvestor.com/article/pe-d...
According to S&P Global Market Intelligence, private equity deal volume fell 22% year-over-year, even as total deal value rose to $154.64 billion. Allocators are now forced to be more selective as they navigate tight budgets.
www.institutionalinvestor.com/article/priv...
BlackRock forecasts that $5 trillion in capital expenditures by 2030 on AI-related supplies could exacerbate inflation. This development poses challenges for policymakers grappling with tighter financial conditions. www.institutionalinvestor.com/article/blac...
Three quarters of surveyed investors plan to increase digital asset allocations this year, with 29 percent targeting more than 5% of their portfolios. This cautious approach reflects demand for regulatory clarity in asset management.
www.institutionalinvestor.com/article/regu...
TCI Fund Management, led by Chris Hohn, experienced an 11.9% decline in March, exceeding the broader market losses of 4.6% for the S&P 500. Such significant losses indicate the challenges of concentrated long strategies. www.institutionalinvestor.com/article/tci-...
The Saginaw Chippewa Indian Tribe’s capital allocation model reduced the performance gap between accounts from 44 to 11 basis points by systematically deploying idle cash. This development supports tribal allocators facing unique investment challenges. www.institutionalinvestor.com/article/perf...
Discovery Capital Management reported a 4.1% loss for March but rose 5.7% for the quarter. This performance contrasts with many hedge funds facing losses during the same period, highlighting its strategic hedging approaches.
www.institutionalinvestor.com/article/prem...
The emergence of GhostClaw, a malware targeting AI system permissions, presents significant operational risks for institutions deploying OpenClaw. Asset managers must reevaluate security protocols to guard against such vulnerabilities.
www.institutionalinvestor.com/article/inst...
The coming decade will challenge financial professionals, emphasizing the need for adaptive learning and resilient decision-making. Peer collaboration and community-driven education are crucial in navigating market complexities. www.institutionalinvestor.com/article/mark...
Allocators are reducing new private equity commitments, with deal volume down 22% year-over-year, as cash remains locked in illiquid portfolios. This trend is forcing CIOs to ration capital and make select investments. www.institutionalinvestor.com/article/priv...
A March report reveals that 75% of institutional investors plan to boost digital asset allocations, with 29% designating over 5% of their portfolios to this sector. Cautious approaches reflect a demand for clearer regulatory frameworks. www.institutionalinvestor.com/article/regu...